Advanced Gastric Cancer. Results Observed in a Private Regional Health Center
Gastric cancer (GC) is the fourth of oncological diseases in women and the first men. For advanced GC (AGC), surgery remains the treatment of choice, which involves performing gastrectomies and D2 lymphadenectomy. The aim of this study is to determine postoperative morbidity (POM), mortality, survival (SV) and recurrence in patients resected by AGC. Retrospective case series of patients with AGC undergoing gastrectomies and LD2, consecutively at the Clínica Mayor in Temuco, between the years 2008 and 2014. The outcome variable was SV. Other variables of interest were: POM, mortality and recurrence. Patients were followed clinically. Descriptive statistics were used, with measures of central tendency and dispersion. Twenty-two patients (68.2 % male) were operated, with a median age of 61 years. The most frequent location was subcardial (45.5 %); the most common type of resection was total gastrectomy (54.5 %). The medium surgical time, resection of lymph nodes, and hospital stay were 155 min, 24 and 6 days respectively. POM was 18.2 %. With a median follow up of 22.5 months, a global actuarial SV was verified to 5 years 37 %, and recurrence of 36.4 %. The results achieved, in terms of POM, mortality and SV series are comparable to national and international centers.